Butrans Related Published Studies
Well-designed clinical trials related to Butrans (Buprenorphine)
Neonatal outcomes and their relationship to maternal buprenorphine dose during
pregnancy. [2014]
A randomized, double-blind evaluation of buprenorphine taper duration in primary
prescription opioid abusers. [2013]
A randomised controlled trial of sublingual buprenorphine-naloxone film versus
tablets in the management of opioid dependence. [2013]
Cocaine use reduction with buprenorphine (CURB): rationale, design, and
methodology. [2013]
Analgesia after feline ovariohysterectomy under midazolam-medetomidine-ketamine
anaesthesia with buprenorphine or butorphanol, and carprofen or meloxicam: a
prospective, randomised clinical trial. [2012]
Effect of buprenorphine dose on treatment outcome. [2012]
Sublingual buprenorphine in acute pain management: a double-blind randomized
clinical trial. [2012]
Efficacy and safety of buprenorphine transdermal system (BTDS) for chronic
moderate to severe low back pain: a randomized, double-blind study. [2011]
Induction of opioid-dependent individuals onto buprenorphine and
buprenorphine/naloxone soluble-films. [2011]
Buprenorphine transdermal system for opioid therapy in patients with chronic low
back pain. [2010]
Bioavailability of buprenorphine from crushed and whole buprenorphine (subutex) tablets. [2010]
Buprenorphine maintenance versus placebo or methadone maintenance for opioid
dependence. [2008]
Retention rate and substance use in methadone and buprenorphine maintenance
therapy and predictors of outcome: results from a randomized study. [2008]
QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized
trial. [2007]
Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single
intravenous administration in healthy volunteers: a randomized, double-blind,
placebo-controlled, crossover study. [2007]
Buprenorphine duration of action: mu-opioid receptor availability and
pharmacokinetic and behavioral indices. [2007]
Comparison of intravenous patient-controlled analgesia with buprenorphine versus
morphine after lumbar spinal fusion--a prospective randomized clinical trial. [2006]
Effects associated with double-blind omission of buprenorphine/naloxone over a
98-h period. [2006]
HIV risk behaviors during pharmacologic treatment for opioid dependence: a
comparison of levomethadyl acetate [corrected] buprenorphine, and methadone. [2006]
Comparison of intrathecal fentanyl and buprenorphine in urological surgery. [2006]
Evaluation of signs of postoperative pain and complications after forelimb
onychectomy in cats receiving buprenorphine alone or with bupivacaine
administered as a four-point regional nerve block. [2006]
Mood and affect during detoxification of opiate addicts: a comparison of
buprenorphine versus methadone. [2005]
Use of sublingual buprenorphine for pain relief in office hysteroscopy. [2005]
Pain management after lumbar spinal fusion surgery using continuous subcutaneous infusion of buprenorphine. [2005]
Buprenorphine versus methadone in the treatment of pregnant opioid-dependent
patients: effects on the neonatal abstinence syndrome. [2005]
Addition of 0.1% bupivacaine to buprenorphine and droperidol in
patient-controlled epidural analgesia improved postoperative pain scores on
coughing after gynecological surgery. [2005]
Methadone versus buprenorphine with contingency management or performance
feedback for cocaine and opioid dependence. [2005]
A double-blind, double-dummy, randomized, prospective pilot study of the partial
mu opiate agonist, buprenorphine, for acute detoxification from heroin. [2005]
Transdermal buprenorphine in the treatment of chronic pain: results of a phase
III, multicenter, randomized, double-blind, placebo-controlled study. [2004]
Depressive symptoms during buprenorphine vs. methadone maintenance: findings from
a randomised, controlled trial in opioid dependence. [2004]
Evaluation of an injection depot formulation of buprenorphine: placebo
comparison. [2004]
Opioid detoxification using high doses of buprenorphine in 24 hours: a
randomized, double blind, controlled clinical trial. [2004]
Depression predicts higher rates of heroin use on desipramine with buprenorphine
than with methadone. [2004]
A dose-effect study of repeated administration of buprenorphine/naloxone on
performance in opioid-dependent volunteers. [2004]
Well-designed clinical trials possibly related to Butrans (Buprenorphine)
Clonidine Maintenance Prolongs Opioid Abstinence and Decouples Stress From
Craving in Daily Life: A Randomized Controlled Trial With Ecological Momentary
Assessment. [2015]
Association of CHRNA5-A3-B4 SNP rs2036527 with smoking cessation therapy response
in African-American smokers. [2014]
Neonatal abstinence syndrome in European and North American neonates: differences
in clinical characteristics derived from a prospective randomized trial. [2014]
Maintenance agonist treatments for opiate-dependent pregnant women. [2013]
Characterizing and improving HIV and hepatitis knowledge among primary
prescription opioid abusers. [2013]
Influence of site differences between urban and rural American and Central
European opioid-dependent pregnant women and neonatal outcome characteristics. [2012]
Effects of multimodal analgesia on the success of mouse embryo transfer surgery. [2011]
Heroin anticraving medications: a systematic review. [2010]
A history of sexual, emotional, or physical abuse predicts adjustment during
opioid maintenance treatment. [2008]
Abuse liability of prescription opioids compared to heroin in morphine-maintained
heroin abusers. [2008]
Enriched analgesic efficacy studies: an assessment by clinical trial simulation. [2006]
Comparison of pharmacological treatments for opioid-dependent adolescents: a
randomized controlled trial. [2005]
Males and females differ in response to opioid agonist medications. [2005]
Oral etodolac, a COX-2 inhibitor, reduces postoperative pain immediately after fast-track cardiac surgery. [2004]
Other research related to Butrans (Buprenorphine)
Initial response as a predictor of 12-week buprenorphine-naloxone treatment
response in a prescription opioid-dependent population. [2015]
Buprenorphine added to bupivacaine prolongs femoral nerve block duration and
improves analgesia in patients undergoing primary total knee arthroplasty-a
randomised prospective double-blind study. [2015]
Buprenorphine pharmacotherapy and behavioral treatment: comparison of outcomes
among prescription opioid users, heroin users and combination users. [2015]
Spontaneous reductions in smoking during double-blind buprenorphine
detoxification. [2014]
Leaving buprenorphine treatment: patients' reasons for cessation of care. [2014]
Patient perspectives on buprenorphine/naloxone: a qualitative study of retention
during the starting treatment with agonist replacement therapies (START) study. [2014]
Pharmacodynamic modelling of placebo and buprenorphine effects on event-related
potentials in experimental pain. [2014]
Evaluation of the perioperative analgesic efficacy of buprenorphine, compared
with butorphanol, in cats. [2014]
A randomized controlled trial of prison-initiated buprenorphine: prison outcomes
and community treatment entry. [2014]
Who benefits from additional drug counseling among prescription opioid-dependent
patients receiving buprenorphine-naloxone and standard medical management? [2014]
The reinforcing and subjective effects of intravenous and intranasal
buprenorphine in heroin users. [2014]
A randomized trial of cognitive behavioral therapy in primary care-based
buprenorphine. [2013]
Once-weekly transdermal buprenorphine application results in sustained and
consistent steady-state plasma levels. [2013]
HIV testing and sexual risk reduction counseling in office-based
buprenorphine/naloxone treatment. [2013]
Buprenorphine implants for treatment of opioid dependence: randomized comparison
to placebo and sublingual buprenorphine/naloxone. [2013]
Methadone and buprenorphine-naloxone are effective in reducing illicit
buprenorphine and other opioid use, and reducing HIV risk behavior--outcomes of a
randomized trial. [2013]
Change in symptoms of erectile dysfunction in depressed men initiating
buprenorphine therapy. [2013]
Time to initiation of treatment for neonatal abstinence syndrome in neonates
exposed in utero to buprenorphine or methadone. [2013]
Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid
analgesic, heroin, and combined users: findings from starting treatment with
agonist replacement therapies (START). [2013]
Postcastration analgesia in ponies using buprenorphine hydrochloride. [2013]
Comparison of efficacy between buprenorphine and tramadol in the detoxification
of opioid (heroin)-dependent subjects. [2013]
Antinociceptive efficacy of buprenorphine and hydromorphone in red-eared slider
turtles (Trachemys scripta elegans). [2012]
Effects of buprenorphine on a cecal ligation and puncture model in C57BL/6 mice. [2012]
Predictors of attrition with buprenorphine/naloxone treatment in opioid dependent
youth. [2012]
Comparison of two formulations of buprenorphine in cats administered by the oral
transmucosal route. [2012]
Health-related quality of life changes associated with buprenorphine treatment
for opioid dependence. [2012]
Comparison of methadone and buprenorphine for opiate detoxification (LEEDS
trial): a randomised controlled trial. [2011]
Adjunctive counseling during brief and extended buprenorphine-naloxone treatment
for prescription opioid dependence: a 2-phase randomized controlled trial. [2011]
Cognitive functioning in opioid-dependent patients treated with buprenorphine,
methadone, and other psychoactive medications: stability and correlates. [2011]
A randomized, double-blind, double-dummy comparison of the efficacy and
tolerability of low-dose transdermal buprenorphine (BuTrans seven-day patches)
with buprenorphine sublingual tablets (Temgesic) in patients with osteoarthritis
pain. [2010]
Other possibly related research studies
Effect of intratesticular lidocaine on isoflurane requirements in dogs undergoing
routine castration. [2012]
Hyperalgesia in heroin dependent patients and the effects of opioid substitution
therapy. [2012]
Preemptive carprofen for peri-operative analgesia in dogs undergoing Tibial
Plateau Leveling Osteotomy (TPLO): a prospective, randomized, blinded, placebo
controlled clinical trial. [2012]
Missing data in substance abuse treatment research: current methods and modern
approaches. [2012]
Heroin maintenance for chronic heroin-dependent individuals. [2011]
Evaluation of dexmedetomidine and ketamine in combination with various opioids as
injectable anesthetic combinations for castration in cats. [2011]
Compensation effects on clinical trial data collection in opioid-dependent young
adults. [2012]
Escitalopram is associated with reductions in pain severity and pain interference
in opioid dependent patients with depressive symptoms. [2011]
Dopamine agonists for the treatment of cocaine dependence. [2011]
Interventions for female drug-using offenders. [2014]
Pharmacological interventions for drug-using offenders. [2013]
Baseline characteristics and treatment outcomes in prescription opioid dependent
patients with and without co-occurring psychiatric disorder. [2014]
Ultrasound-guided pudendal nerve block in cats undergoing perineal urethrostomy:
a prospective, randomised, investigator-blind, placebo-controlled clinical trial. [2014]
Psychometric properties of the adjective rating scale for withdrawal across
treatment groups, gender, and over time. [2014]
Days of heroin use predict poor self-reported health in hospitalized heroin
users. [2013]
Assessment of postoperative analgesia after application of ultrasound-guided
regional anesthesia for surgery in a swine femoral fracture model. [2013]
Comparison of a drug versus money and drug versus drug self-administration choice
procedure with oxycodone and morphine in opioid addicts. [2013]
Concordance between self-report and urine drug screen data in adolescent opioid
dependent clinical trial participants. [2013]
Opioid antagonists for smoking cessation. [2013]
Slow-release oral morphine as maintenance therapy for opioid dependence. [2013]
Testing use of payers to facilitate evidence-based practice adoption: protocol
for a cluster-randomized trial. [2013]
Neurofeedback training for opiate addiction: improvement of mental health and
craving. [2013]
Enhancing motivation within a rapid opioid substitution treatment feasibility
RCT: a nested qualitative study. [2014]
|